206 related articles for article (PubMed ID: 16556277)
21. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial.
Veien NK; Bjerke JR; Rossmann-Ringdahl I; Jakobsen HB
Br J Dermatol; 1997 Oct; 137(4):581-6. PubMed ID: 9390335
[TBL] [Abstract][Full Text] [Related]
22. Intermittent cyclosporin A treatment of severe plaque psoriasis. Long-term follow-up of 26 patients.
Peluso AM; Bardazzi F; Tosti A; Varotti C
Acta Derm Venereol Suppl (Stockh); 1994; 186():90-1. PubMed ID: 8073851
[TBL] [Abstract][Full Text] [Related]
23. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
Lebwohl M; Menter A; Weiss J; Clark SD; Flores J; Powers J; Balin AK; Kempers S; Glinert RJ; Fleming T; Liu Y; Graeber M; Pariser DM
J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
[TBL] [Abstract][Full Text] [Related]
24. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
25. Four cases of sebopsoriasis or seborrheic dermatitis of the face and scalp successfully treated with 1a-24 (R)-dihydroxycholecalciferol (tacalcitol) cream.
Nakayama J
Eur J Dermatol; 2000; 10(7):528-32. PubMed ID: 11056423
[TBL] [Abstract][Full Text] [Related]
26. Open trial of topical tacalcitol [1 alpha 24(OH)2D3] and solar irradiation for vitiligo vulgaris: upregulation of c-Kit mRNA by cultured melanocytes.
Katayama I; Ashida M; Maeda A; Eishi K; Murota H; Bae SJ
Eur J Dermatol; 2003; 13(4):372-6. PubMed ID: 12948918
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological profiles of high-concentration (20 microg/g) tacalcitol ointment: effects on cutaneous inflammation, epidermal proliferation, and differentiation in mice.
Sato H; Ogino Y; Takagi H; Hata J; Asano S; Ohta T; Komoriya K
J Dermatol; 2003 Jul; 30(7):510-24. PubMed ID: 12928540
[TBL] [Abstract][Full Text] [Related]
28. Efficacious treatment of psoriasis with low-dose and intermittent cyclosporin microemulsion therapy.
Ito T; Furukawa F; Iwatsuki K; Matsue H; Shimada S; Takigawa M; Tokura Y
J Dermatol; 2014 May; 41(5):377-81. PubMed ID: 24628433
[TBL] [Abstract][Full Text] [Related]
29. Photochemotherapy combined with tacalcitol occlusive dressing in the treatment of wide-spread psoriasis vulgaris.
Fujii N; Danno K; Tanaka T
J Dermatol; 2010 Aug; 37(8):743-6. PubMed ID: 20649720
[No Abstract] [Full Text] [Related]
30. Clinical usefulness of a supplementary cyclosporin administration with a topical application of maxacalcitol ointment for patients with moderate psoriasis vulgaris.
Abe M; Syuto T; Hasegawa M; Yokoyama Y; Ishikawa O
J Dermatol; 2009 Apr; 36(4):197-201. PubMed ID: 19348657
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis.
Kircik L
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s9-16. PubMed ID: 19702031
[TBL] [Abstract][Full Text] [Related]
32. Tacalcitol ointment for long-term control of chronic plaque psoriasis in dermatological practice.
Lambert J; Trompke C
Dermatology; 2002; 204(4):321-4. PubMed ID: 12077538
[TBL] [Abstract][Full Text] [Related]
33. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
[TBL] [Abstract][Full Text] [Related]
34. Clinical and immunohistochemical assessment of the effect of cyclosporin in keratinocytes and dermal dendrocytes in psoriasis.
Lago E; Carneiro S; Cuzzi T; Magalhães G; Cássia F; Pessanha F; Ramos-e-Silva M
J Cutan Pathol; 2007 Jan; 34(1):15-21. PubMed ID: 17214849
[TBL] [Abstract][Full Text] [Related]
35. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M
Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
[TBL] [Abstract][Full Text] [Related]
36. Profile of clinical efficacy and safety of topical tacalcitol.
Leone G; Pacifico A
Acta Biomed; 2005 Apr; 76(1):13-9. PubMed ID: 16116820
[TBL] [Abstract][Full Text] [Related]
37. Treatment of psoriasis with intermittent short course cyclosporin (Neoral). A multicentre study.
Berth-Jones J; Henderson CA; Munro CS; Rogers S; Chalmers RJ; Boffa MJ; Norris PG; Friedmann PS; Graham-Brown RA; Dowd PM; Marks R; Sumner MJ
Br J Dermatol; 1997 Apr; 136(4):527-30. PubMed ID: 9155952
[TBL] [Abstract][Full Text] [Related]
38. Tacalcitol: A useful adjunct to narrow band ultraviolet B phototherapy in psoriasis.
Aggarwal P; Aggarwal K; Jain VK
J Dermatolog Treat; 2016 Nov; 27(6):546-551. PubMed ID: 27052200
[TBL] [Abstract][Full Text] [Related]
39. Cyclosporin in psoriasis: continuous monotherapy versus intermittent long-term therapy.
Ozawa A; Sugai J; Ohkido M; Ohtsuki M; Nakagawa H; Kitahara H; Tamaki K; Urabe K; Nakayama J; Horikoshi T; Morimoto Y; Jimbow K
Eur J Dermatol; 1999; 9(3):218-23. PubMed ID: 10210789
[TBL] [Abstract][Full Text] [Related]
40. Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis.
van de Kerkhof PC; Berth-Jones J; Griffiths CE; Harrison PV; Hönigsmann H; Marks R; Roelandts R; Schöpf E; Trompke C
Br J Dermatol; 2002 Mar; 146(3):414-22. PubMed ID: 11952541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
